- Home
- RRBI vs TRVI Comparison
RRBI vs TRVI Comparison
Compare RRBI & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- TRVI
- Stock Information
- Founded
- RRBI 1998
- TRVI 2011
- Country
- RRBI United States
- TRVI United States
- Employees
- RRBI N/A
- TRVI N/A
- Industry
- RRBI Hotels/Resorts
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- RRBI Consumer Discretionary
- TRVI Health Care
- Exchange
- RRBI Nasdaq
- TRVI Nasdaq
- Market Cap
- RRBI 357.4M
- TRVI 341.4M
- IPO Year
- RRBI 2019
- TRVI 2019
- Fundamental
- Price
- RRBI $52.39
- TRVI $3.56
- Analyst Decision
- RRBI
- TRVI Strong Buy
- Analyst Count
- RRBI 0
- TRVI 8
- Target Price
- RRBI N/A
- TRVI $9.31
- AVG Volume (30 Days)
- RRBI 10.9K
- TRVI 659.4K
- Earning Date
- RRBI 01-31-2025
- TRVI 03-19-2025
- Dividend Yield
- RRBI 0.68%
- TRVI N/A
- EPS Growth
- RRBI N/A
- TRVI N/A
- EPS
- RRBI 4.75
- TRVI N/A
- Revenue
- RRBI $106,383,000.00
- TRVI N/A
- Revenue This Year
- RRBI N/A
- TRVI N/A
- Revenue Next Year
- RRBI $7.61
- TRVI N/A
- P/E Ratio
- RRBI $11.19
- TRVI N/A
- Revenue Growth
- RRBI N/A
- TRVI N/A
- 52 Week Low
- RRBI $42.78
- TRVI $1.30
- 52 Week High
- RRBI $62.13
- TRVI $4.68
- Technical
- Relative Strength Index (RSI)
- RRBI 43.85
- TRVI 43.13
- Support Level
- RRBI $50.66
- TRVI $3.63
- Resistance Level
- RRBI $52.56
- TRVI $4.06
- Average True Range (ATR)
- RRBI 1.45
- TRVI 0.30
- MACD
- RRBI 0.17
- TRVI -0.11
- Stochastic Oscillator
- RRBI 54.04
- TRVI 0.44
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.